{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:31:50Z","timestamp":1793457110431,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11102-026-01745-y","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:48:16Z","timestamp":1787230096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Revival of neurophysin-I as a complementary biomarker for circulating oxytocin"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8619-3349","authenticated-orcid":false,"given":"Elizabeth A.","family":"Lawson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"1745_CR1","doi-asserted-by":"crossref","unstructured":"Atila C, Murugesu R, Rudin D, Luethi D, Liechti ME, Christ-Crain M (2026) Absence of detectable circadian rhythmicity of neurophysin I, a surrogate marker for oxytocin. Pituitary 29(2):62.","DOI":"10.1007\/s11102-026-01670-0"},{"key":"1745_CR2","doi-asserted-by":"crossref","unstructured":"Schweizer J, Schilbach K (2026) Old and new pituitary biomarkers: evidence for sex-specificity. Pituitary 29(2):52.","DOI":"10.1007\/s11102-026-01650-4"},{"key":"1745_CR3","doi-asserted-by":"publisher","first-page":"106951","DOI":"10.1016\/j.psyneuen.2023.106951","volume":"161","author":"EL MacLean","year":"2024","unstructured":"MacLean EL, Carranza E, Gnanadesikan GE, King KM, Allen AM, Linde-Krieger LB, Feldman R, White-Traut RC, Hammock EAD, Carter CS, Leng G, Tecot SR, Bell AF (2024) Neurophysin I is an analytically robust surrogate biomarker for oxytocin. Psychoneuroendocrinology 161:106951","journal-title":"Psychoneuroendocrinology"},{"issue":"1\u20132","key":"1745_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0167-0115(93)90175-8","volume":"45","author":"E Breslow","year":"1993","unstructured":"Breslow E (1993) Structure and folding properties of neurophysin and its peptide complexes: biological implications. Regul Pept 45(1\u20132):15\u201319","journal-title":"Regul Pept"},{"key":"1745_CR5","doi-asserted-by":"publisher","first-page":"171221","DOI":"10.1016\/j.peptides.2024.171221","volume":"177","author":"E Lahaye","year":"2024","unstructured":"Lahaye E, Fetissov SO (2024) Functional role of immunoglobulin G as an oxytocin-carrier protein. Peptides 177:171221","journal-title":"Peptides"},{"key":"1745_CR6","doi-asserted-by":"publisher","first-page":"170649","DOI":"10.1016\/j.peptides.2021.170649","volume":"146","author":"SM Cherepanov","year":"2021","unstructured":"Cherepanov SM, Gerasimenko M, Yuhi T, Shabalova A, Zhu H, Yokoyama S, Salmina AB, Munesue SI, Harashima A, Yamamoto Y, Higashida H (2021) An improved sample extraction method reveals that plasma receptor for advanced glycation end-products (RAGE) modulates circulating free oxytocin in mice. Peptides 146:170649","journal-title":"Peptides"},{"key":"1745_CR7","doi-asserted-by":"publisher","first-page":"31693","DOI":"10.1038\/srep31693","volume":"6","author":"OK Brandtzaeg","year":"2016","unstructured":"Brandtzaeg OK, Johnsen E, Roberg-Larsen H, Seip KF, MacLean EL, Gesquiere LR, Leknes S, Lundanes E, Wilson SR (2016) Proteomics tools reveal startlingly high amounts of oxytocin in plasma and serum. Sci Rep 6:31693","journal-title":"Sci Rep"},{"issue":"5","key":"1745_CR8","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1210\/jcem-57-5-947","volume":"57","author":"JA Amico","year":"1983","unstructured":"Amico JA, Tenicela R, Johnston J, Robinson AG (1983) A time-dependent peak of oxytocin exists in cerebrospinal fluid but not in plasma of humans. J Clin Endocrinol Metab 57(5):947\u2013951","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1745_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0196-9781(82)90019-5","volume":"3","author":"G Gauquelin","year":"1982","unstructured":"Gauquelin G, Geelen G, Allevard-Burguburu AM, Cellier M, Sempore B, Louis F, Legros JJ, Gharib C (1982) Presence of neurophysins I and II in the human pineal gland: comparison with the content of neurohypophyseal hormones. Peptides 3(5):805\u2013809","journal-title":"Peptides"},{"issue":"1","key":"1745_CR10","doi-asserted-by":"publisher","first-page":"e200003","DOI":"10.2142\/biophysico.bppb-v20.0003","volume":"20","author":"K Fujimoto","year":"2023","unstructured":"Fujimoto K, Inada K, Oka K, Ito E (2023) Revisiting oxytocin generation in keratinocytes. Biophys Physicobiol 20(1):e200003","journal-title":"Biophys Physicobiol"},{"issue":"5","key":"1745_CR11","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1523\/JNEUROSCI.04-05-01262.1984","volume":"4","author":"JD White","year":"1984","unstructured":"White JD, Krause JE, McKelvy JF (1984) In vivo biosynthesis and transport of oxytocin, vasopressin, and neurophysins to posterior pituitary and nucleus of the solitary tract. J Neurosci 4(5):1262\u20131270","journal-title":"J Neurosci"},{"key":"1745_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/BF00500641","volume":"89","author":"UM Moll","year":"1988","unstructured":"Moll UM, Lane BL, Robert F, Geenen V, Legros JJ (1988) The neuroendocrine thymus. Histochemistry 89:385\u2013390","journal-title":"Histochemistry"},{"key":"1745_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1600-0625.2012.01507.x","volume":"21","author":"S Denda","year":"2012","unstructured":"Denda S, Takei K, Kumamoto J, Goto M, Tsutsumi M, Mitsuhiro D (2012) Oxytocin is expressed in epidermal keratinocytes and released upon stimulation with adenosine 5\u2018[y-thio]triphosphate in vitro. Exp Dermatol 21:535\u2013561","journal-title":"Exp Dermatol"},{"issue":"2","key":"1745_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00441-004-0968-5","volume":"318","author":"K Whittington","year":"2004","unstructured":"Whittington K, Assinder S, Gould M, Nicholson H (2004) Oxytocin, oxytocin-associated neurophysin and the oxytocin receptor in the human prostate. Cell Tissue Res 318(2):375\u2013382","journal-title":"Cell Tissue Res"},{"issue":"1","key":"1745_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/aja.1001790104","volume":"179","author":"FS Khan-Dawood","year":"1987","unstructured":"Khan-Dawood FS (1987) Immunocytochemical localization of oxytocin and neurophysin in human corpora lutea. Am J Anat 179(1):18\u201324","journal-title":"Am J Anat"},{"issue":"2","key":"1745_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1152\/physrev.2001.81.2.629","volume":"81","author":"G Gimpl","year":"2001","unstructured":"Gimpl G, Fahrenholz F (2001) The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81(2):629\u2013683","journal-title":"Physiol Rev"},{"issue":"1","key":"1745_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s44192-023-00048-z","volume":"3","author":"H Vaeroy","year":"2023","unstructured":"Vaeroy H, Lahaye E, Dubessy C, Benard M, Nicol M, Cherifi Y, Takhlidjt S, do Rego JL, do Rego JC, Chartrel N, Fetissov SO (2023) Immunoglobulin G is a natural oxytocin carrier which modulates oxytocin receptor signaling: relevance to aggressive behavior in humans. Discov Ment Health 3(1):21","journal-title":"Discov Ment Health"},{"key":"1745_CR18","doi-asserted-by":"publisher","first-page":"109394","DOI":"10.1016\/j.mehy.2019.109394","volume":"133","author":"K Uvnas Moberg","year":"2019","unstructured":"Uvnas Moberg K, Handlin L, Kendall-Tackett K, Petersson M (2019) Oxytocin is a principal hormone that exerts part of its effects by active fragments. Med Hypotheses 133:109394","journal-title":"Med Hypotheses"},{"key":"1745_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.neuropharm.2018.10.036","volume":"144","author":"SS Moy","year":"2019","unstructured":"Moy SS, Teng BL, Nikolova VD, Riddick NV, Simpson CD, Van Deusen A, Janzen WP, Sassano MF, Pedersen CA, Jarstfer MB (2019) Prosocial effects of an oxytocin metabolite, but not synthetic oxytocin receptor agonists, in a mouse model of autism. Neuropharmacology 144:301\u2013311","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"1745_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0014-2999(83)90449-1","volume":"94","author":"JP Burbach","year":"1983","unstructured":"Burbach JP, Bohus B, Kovacs GL, Van Nispen JW, Greven HM, De Wied D (1983) Oxytocin is a precursor of potent behaviourally active neuropeptides. Eur J Pharmacol 94(1\u20132):125\u2013131","journal-title":"Eur J Pharmacol"},{"key":"1745_CR21","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1749-6632.1975.tb34193.x","volume":"248","author":"O Trygstad","year":"1975","unstructured":"Trygstad O, Foss I, Sletten K (1975) Metabolic activities of human neurophysins. Ann N Y Acad Sci 248:304\u2013316","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"1745_CR22","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/0026-0495(77)90031-2","volume":"26","author":"C Sinding","year":"1977","unstructured":"Sinding C, Robinson AG (1977) A review of neurophysins. Metabolism 26(12):1355\u20131370","journal-title":"Metabolism"},{"key":"1745_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.psyneuen.2019.05.018","volume":"107","author":"EL MacLean","year":"2019","unstructured":"MacLean EL, Wilson SR, Martin WL, Davis JM, Nazarloo HP, Carter CS (2019) Challenges for measuring oxytocin: The blind men and the elephant? Psychoneuroendocrinology 107:225\u2013231","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"1745_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41380-022-01719-z","volume":"28","author":"BA Tabak","year":"2023","unstructured":"Tabak BA, Leng G, Szeto A, Parker KJ, Verbalis JG, Ziegler TE, Lee MR, Neumann ID, Mendez AJ (2023) Advances in human oxytocin measurement: challenges and proposed solutions. Mol Psychiatry 28(1):127\u2013140","journal-title":"Mol Psychiatry"},{"key":"1745_CR25","doi-asserted-by":"publisher","first-page":"105368","DOI":"10.1016\/j.psyneuen.2021.105368","volume":"132","author":"GE Gnanadesikan","year":"2021","unstructured":"Gnanadesikan GE, Hammock EAD, Tecot SR, Carter CS, MacLean EL (2021) Specificity of plasma oxytocin immunoassays: A comparison of commercial assays and sample preparation techniques using oxytocin knockout and wildtype mice. Psychoneuroendocrinology 132:105368","journal-title":"Psychoneuroendocrinology"},{"key":"1745_CR26","doi-asserted-by":"publisher","first-page":"105827","DOI":"10.1016\/j.psyneuen.2022.105827","volume":"143","author":"GE Gnanadesikan","year":"2022","unstructured":"Gnanadesikan GE, Hammock EAD, Tecot SR, Lewis RJ, Hart R, Carter CS, MacLean EL (2022) What are oxytocin assays measuring? Epitope mapping, metabolites, and comparisons of wildtype & knockout mouse urine. Psychoneuroendocrinology 143:105827","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"1745_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/PSY.0b013e31821df0c2","volume":"73","author":"A Szeto","year":"2011","unstructured":"Szeto A, McCabe PM, Nation DA, Tabak BA, Rossetti MA, McCullough ME, Schneiderman N, Mendez AJ (2011) Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin. Psychosom Med 73(5):393\u2013400","journal-title":"Psychosom Med"},{"key":"1745_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jpba.2019.04.023","volume":"173","author":"D Liu","year":"2019","unstructured":"Liu D, Han X, Liu X, Cheng M, He M, Rainer G, Gao H, Zhang X (2019) Measurement of ultra-trace level of intact oxytocin in plasma using SALLE combined with nano-LC-MS. J Pharm Biomed Anal 173:62\u201367","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"1745_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/dta.2475","volume":"11","author":"AA Franke","year":"2019","unstructured":"Franke AA, Li X, Menden A, Lee MR, Lai JF (2019) Oxytocin analysis from human serum, urine, and saliva by orbitrap liquid chromatography-mass spectrometry. Drug Test Anal 11(1):119\u2013128","journal-title":"Drug Test Anal"},{"issue":"1","key":"1745_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ab.2011.04.041","volume":"416","author":"G Zhang","year":"2011","unstructured":"Zhang G, Zhang Y, Fast DM, Lin Z, Steenwyk R (2011) Ultra sensitive quantitation of endogenous oxytocin in rat and human plasma using a two-dimensional liquid chromatography-tandem mass spectrometry assay. Anal Biochem 416(1):45\u201352","journal-title":"Anal Biochem"},{"key":"1745_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/pmic.201600232","volume":"17","author":"RD Semba","year":"2017","unstructured":"Semba RD, Zhang P, Zhu M, Fabbri E, Gonzalez-Freire M, Moaddel R, Geng-Spyropoulos M, Ferrucci L (2017) A targeted proteomic assay for the measurement of plasma proteoforms related to human aging phenotypes. Proteomics 17:15\u201316","journal-title":"Proteomics"},{"issue":"2","key":"1745_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1172\/JCI107939","volume":"55","author":"AG Robinson","year":"1975","unstructured":"Robinson AG (1975) Isolation, assay, and secretion of individual human neurophysins. J Clin Invest 55(2):360\u2013367","journal-title":"J Clin Invest"},{"issue":"3","key":"1745_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1365-2265.1979.tb02079.x","volume":"10","author":"EM Dax","year":"1979","unstructured":"Dax EM, Clappison BH, Pullan PT, Pepperell R, Johnston CI (1979) Individual neurophysin concentrations in the pituitary and circulation of humans. Clin Endocrinol (Oxf) 10(3):253\u2013263","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1745_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1210\/jcem-41-1-54","volume":"91","author":"JJ Legros","year":"1975","unstructured":"Legros JJ, Franchimont P, Burger H (1975) Variations of Neurohypophysial Function in Normally Cycling Women. J Clin Endocrinol Metab 91:54\u201359","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1745_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2302\/kjm.29.153","volume":"29","author":"A Nakayama","year":"1980","unstructured":"Nakayama A, Makino T, Nagai T, Nakazawa K, Suzuki H, Iwashita M, Yokokura T, Ohno T, Iizuka R (1980) Human neurophysins during pregnancy, puerperium and menstrual cycles. Keio J Med 29(4):153\u2013161","journal-title":"Keio J Med"},{"issue":"12","key":"1745_CR36","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/0026-0495(71)90040-0","volume":"20","author":"AG Robinson","year":"1971","unstructured":"Robinson AG, Zimmerman EA, Frantz AG (1971) Physiologic investigation of posterior pituitary binding proteins neurophysin I and neurophysin II. Metabolism 20(12):1148\u20131155","journal-title":"Metabolism"},{"issue":"3","key":"1745_CR37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1677\/joe.0.0460347","volume":"46","author":"JD Cleverley","year":"1970","unstructured":"Cleverley JD, Folley SJ (1970) The blood levels of oxytocin during machine milking in cows with some observations on its half-life in the circulation. J Endocrinol 46(3):347\u2013361","journal-title":"J Endocrinol"},{"key":"1745_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1749-6632.1975.tb34190.x","volume":"248","author":"MC Tissot-Berthet","year":"1975","unstructured":"Tissot-Berthet MC, Reinharz AC, Vallotton MB (1975) Radioimmunoassay of neurophysin I and II in human plasma. Ann N Y Acad Sci 248:257\u2013271","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"1745_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI107745","volume":"54","author":"AG Robinson","year":"1974","unstructured":"Robinson AG (1974) Elevation of plasma neurophysin in women on oral contraceptives. J Clin Invest 54(1):209\u2013212","journal-title":"J Clin Invest"},{"issue":"6","key":"1745_CR40","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1210\/jcem-53-6-1229","volume":"53","author":"JA Amico","year":"1981","unstructured":"Amico JA, Seif SM, Robinson AG (1981) Elevation of oxytocin and the oxytocin-associated neurophysin in the plasma of normal women during midcycle. J Clin Endocrinol Metab 53(6):1229\u20131232","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1745_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0300-595X(77)80066-2","volume":"6","author":"AG Robinson","year":"1977","unstructured":"Robinson AG (1977) The neurophysins in health and disease. Clin Endocrinol Metab 6(1):261\u2013275","journal-title":"Clin Endocrinol Metab"},{"issue":"4","key":"1745_CR42","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/ejendo\/lvaf078","volume":"192","author":"C Atila","year":"2025","unstructured":"Atila C, Nikaj A, Leibnitz S, Liechti ME, Christ-Crain M (2025) Neurophysin I: a reliable, novel, and robust biomarker for oxytocin. Eur J Endocrinol 192(4):502\u2013510","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1745_CR43","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1749-6632.1975.tb34189.x","volume":"248","author":"AG Robinson","year":"1975","unstructured":"Robinson AG (1975) Radioimmunoassay of Neurophysin Proteins: Utilization of Specific Neurophysin Assays to Demonstrate Independent Secretion of Different Neurophysins IN VIVO. Ann N Y Acad Sci 248(1):246\u2013256","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"1745_CR44","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1186\/s12884-025-07868-7","volume":"25","author":"AM Perkeybile","year":"2025","unstructured":"Perkeybile AM, Kenkel WM, Yee JR, Waugh RE, Lillard TS, Ferris CF, Carter CS, Connelly JJ (2025) Oxytocin treatment at birth accelerates an epigenetic shift in the oxytocin receptor gene in the maternal brain. BMC Pregnancy Childbirth 25(1):777","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01745-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01745-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01745-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:12:01Z","timestamp":1793455921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01745-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1745"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01745-y","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"26 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EAL receives grant support and research study drug from Tonix Pharmaceuticals, is a consultant\/has stock options for Bliss Metrics, and receives royalties from UpToDate. EAL and\/or immediate family member holds\/recently held stock in Thermo Fisher Scientific, Zoetis, Danaher Corporation, Intuitive Surgical, West Pharmaceutical Services, Gilead Sciences, Illumina, and Elevance Health. EAL is an inventor on PCTUS2025\/030536 entitled, \u201cOxytocin-based therapeutics to improve cognitive control in individuals with attention deficit hyperactive disorder\u201d filed on May 22, 2025.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"141"}}